|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jeon Y, Jang ES, Choi YS, Kim JW and Jeong
SH: Glypican-3 level assessed by the enzyme-linked immunosorbent
assay is inferior to alpha-fetoprotein level for hepatocellular
carcinoma diagnosis. Clin Mol Hepatol. 22:359–365. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Milane L, Singh A, Mattheolabakis G,
Suresh M and Amiji MM: Exosome mediated communication within the
tumor microenvironment. J Control Release. 219:278–294. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu DD, Wu Y, Shen HY, Lv MM, Chen WX,
Zhang XH, Zhong SL, Tang JH and Zhao JH: Exosomes in development,
metastasis and drug resistance of breast cancer. Cancer Sci.
106:959–964. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang Y, Cui Y, Li Z, Jiao Z, Zhang Y, He
Y, Chen G, Zhou Q, Wang W, Zhou X, et al: Radiation-induced
miR-208a increases the proliferation and radioresistance by
targeting p21 in human lung cancer cells. J Exp Clin Cancer Res.
35:72016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Soung YH, Nguyen T, Cao H, Lee J and Chung
J: Emerging roles of exosomes in cancer invasion and metastasis.
BMB Rep. 49:18–25. 2016. View Article : Google Scholar :
|
|
9
|
Riches A, Campbell E, Borger E and Powis
S: Regulation of exosome release from mammary epithelial and breast
cancer cells - a new regulatory pathway. Eur J Cancer.
50:1025–1034. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang N, Li S, Li G, Zhang S, Tang X, Ni S,
Jian X, Xu C, Zhu J and Lu M: The role of extracellular vesicles in
mediating progression, metastasis and potential treatment of
hepatocellular carcinoma. Oncotarget. 8:3683–3695. 2017.
|
|
11
|
Wang Z, Chen JQ, Liu JL and Tian L:
Exosomes in tumor microenvironment: Novel transporters and
biomarkers. J Transl Med. 14:2972016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Théry C, Zitvogel L and Amigorena S:
Exosomes: Composition, biogenesis and function. Nat Rev Immunol.
2:569–579. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wolf P: The nature and significance of
platelet products in human plasma. Br J Haematol. 13:269–288. 1967.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Harding C, Heuser J and Stahl P:
Receptor-mediated endocytosis of transferrin and recycling of the
transferrin receptor in rat reticulocytes. J Cell Biol. 97:329–339.
1983. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Johnstone RM, Adam M, Hammond JR, Orr L
and Turbide C: Vesicle formation during reticulocyte maturation.
Association of plasma membrane activities with released vesicles
(exosomes). J Biol Chem. 262:9412–9420. 1987.PubMed/NCBI
|
|
16
|
Mathivanan S, Ji H and Simpson RJ:
Exosomes: Extracellular organelles important in intercellular
communication. J Proteomics. 73:1907–1920. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oosthuyzen W, Sime NE, Ivy JR, Turtle EJ,
Street JM, Pound J, Bath LE, Webb DJ, Gregory CD, Bailey MA, et al:
Quantification of human urinary exosomes by nanoparticle tracking
analysis. J Physiol. 591:5833–5842. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Street JM, Barran PE, Mackay CL, Weidt S,
Balmforth C, Walsh TS, Chalmers RT, Webb DJ and Dear JW:
Identification and proteomic profiling of exosomes in human
cerebrospinal fluid. J Transl Med. 10:52012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang H, Hou L, Li A, Duan Y, Gao H and
Song X: Expression of serum exosomal microRNA-21 in human
hepatocellular carcinoma. Biomed Res Int.
2014:8648942014.PubMed/NCBI
|
|
20
|
Kogure T, Lin WL, Yan IK, Braconi C and
Patel T: Intercellular nanovesicle-mediated microRNA transfer: A
mechanism of environmental modulation of hepatocellular cancer cell
growth. Hepatology. 54:1237–1248. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yuyama K, Sun H, Mitsutake S and Igarashi
Y: Sphingolipid-modulated exosome secretion promotes clearance of
amyloid-β by microglia. J Biol Chem. 287:10977–10989. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Herreros-Villanueva M and Bujanda L:
Glypican-1 in exosomes as biomarker for early detection of
pancreatic cancer. Ann Transl Med. 4:642016.PubMed/NCBI
|
|
23
|
Ludwig AK and Giebel B: Exosomes: Small
vesicles participating in intercellular communication. Int J
Biochem Cell Biol. 44:11–15. 2012. View Article : Google Scholar
|
|
24
|
Tkach M and Théry C: Communication by
extracellular vesicles: Where we are and where we need to go. Cell.
164:1226–1232. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shrivastava S, Devhare P, Sujijantarat N,
Steele R, Kwon YC, Ray R and Ray RB: Knockdown of autophagy
inhibits infectious hepatitis C virus release by the exosomal
pathway. J Virol. 90:1387–1396. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Conigliaro A, Costa V, Lo Dico A, Saieva
L, Buccheri S, Dieli F, Manno M, Raccosta S, Mancone C, Tripodi M,
et al: CD90+ liver cancer cells modulate endothelial
cell phenotype through the release of exosomes containing H19
lncRNA. Mol Cancer. 14:1552015. View Article : Google Scholar
|
|
27
|
Aucher A, Rudnicka D and Davis DM:
MicroRNAs transfer from human macrophages to hepato-carcinoma cells
and inhibit proliferation. J Immunol. 191:6250–6260. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Putz U, Howitt J, Doan A, Goh CP, Low LH,
Silke J and Tan SS: The tumor suppressor PTEN is exported in
exosomes and has phosphatase activity in recipient cells. Sci
Signal. 5:ra702012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Azmi AS, Bao B and Sarkar FH: Exosomes in
cancer development, metastasis, and drug resistance: A
comprehensive review. Cancer Metastasis Rev. 32:623–642. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Whiteside TL: Immune modulation of T-cell
and NK (natural killer) cell activities by TEXs (tumour-derived
exosomes). Biochem Soc Trans. 41:245–251. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chiba M, Kimura M and Asari S: Exosomes
secreted from human colorectal cancer cell lines contain mRNAs,
microRNAs and natural antisense RNAs, that can transfer into the
human hepatoma HepG2 and lung cancer A549 cell lines. Oncol Rep.
28:1551–1558. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu Y, Xia F, Ma L, Shan J, Shen J, Yang Z,
Liu J, Cui Y, Bian X, Bie P, et al: MicroRNA-122 sensitizes HCC
cancer cells to adriamycin and vincristine through modulating
expression of MDR and inducing cell cycle arrest. Cancer Lett.
310:160–169. 2011.PubMed/NCBI
|
|
33
|
Wang B, Majumder S, Nuovo G, Kutay H,
Volinia S, Patel T, Schmittgen TD, Croce C, Ghoshal K and Jacob ST:
Role of microRNA-155 at early stages of hepatocarcinogenesis
induced by choline-deficient and amino acid-defined diet in C57BL/6
mice. Hepatology. 50:1152–1161. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li S, Fu H, Wang Y, Tie Y, Xing R, Zhu J,
Sun Z, Wei L and Zheng X: MicroRNA-101 regulates expression of the
v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene
in human hepatocellular carcinoma. Hepatology. 49:1194–1202. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Varnholt H, Drebber U, Schulze F,
Wedemeyer I, Schirmacher P, Dienes HP and Odenthal M: MicroRNA gene
expression profile of hepatitis C virus-associated hepatocellular
carcinoma. Hepatology. 47:1223–1232. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang YF, Wang F, Xiao JJ, Song Y, Zhao YY,
Cao Y, Bei YH and Yang CQ: MiR-222 overexpression promotes
proliferation of human hepatocellular carcinoma HepG2 cells by
downregulating p27. Int J Clin Exp Med. 7:893–902. 2014.PubMed/NCBI
|
|
38
|
Gramantieri L, Ferracin M, Fornari F,
Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E,
Grazi GL, et al: Cyclin G1 is a target of miR-122a, a microRNA
frequently downregulated in human hepatocellular carcinoma. Cancer
Res. 67:6092–6099. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang G, Zhu S, Gu Y, Chen Q, Liu X and Fu
H: MicroRNA-145 and microRNA-133a inhibited proliferation,
migration, and invasion, while promoted apoptosis in hepatocellular
carcinoma cells via targeting FSCN1. Dig Dis Sci. 60:3044–3052.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang Q, Yu X, Li Q, Qin L, Tan S, Zeng X,
Qiu X, Tang B, Jin J, Liao W, et al: Association between miR-199a
rs74723057 and MET rs1621 polymorphisms and the risk of
hepatocellular carcinoma. Oncotarget. 7:79365–79371.
2016.PubMed/NCBI
|
|
41
|
Huang XH, Wang Q, Chen JS, Fu XH, Chen XL,
Chen LZ, Li W, Bi J, Zhang LJ, Fu Q, et al: Bead-based microarray
analysis of microRNA expression in hepatocellular carcinoma:
miR-338 is downregulated. Hepatol Res. 39:786–794. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fornari F, Ferracin M, Trerè D, Milazzo M,
Marinelli S, Galassi M, Venerandi L, Pollutri D, Patrizi C, Borghi
A, et al: Circulating microRNAs, miR-939, miR-595, miR-519d and
miR-494, identify cirrhotic patients with HCC. PLoS One.
10:e01414482015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li Y, Zhang L, Liu F, Xiang G, Jiang D and
Pu X: Identification of endogenous controls for analyzing serum
exosomal miRNA in patients with hepatitis B or hepatocellular
carcinoma. Dis Markers. 2015:8935942015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wei JX, Lv LH, Wan YL, Cao Y, Li GL, Lin
HM, Zhou R, Shang CZ, Cao J, He H, et al: Vps4A functions as a
tumor suppressor by regulating the secretion and uptake of exosomal
microRNAs in human hepatoma cells. Hepatology. 61:1284–1294. 2015.
View Article : Google Scholar :
|
|
45
|
Basu S and Bhattacharyya SN: Insulin-like
growth factor-1 prevents miR-122 production in neighbouring cells
to curtail its intercellular transfer to ensure proliferation of
human hepatoma cells. Nucleic Acids Res. 42:7170–7185. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lou G, Song X, Yang F, Wu S, Wang J, Chen
Z and Liu Y: Exosomes derived from miR-122-modified adipose
tissue-derived MSCs increase chemosensitivity of hepatocellular
carcinoma. J Hematol Oncol. 8:1222015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pan Q, Ramakrishnaiah V, Henry S,
Fouraschen S, de Ruiter PE, Kwekkeboom J, Tilanus HW, Janssen HL
and van der Laan LJ: Hepatic cell-to-cell transmission of small
silencing RNA can extend the therapeutic reach of RNA interference
(RNAi). Gut. 61:1330–1339. 2012. View Article : Google Scholar
|
|
48
|
Sugimachi K, Matsumura T, Hirata H, Uchi
R, Ueda M, Ueo H, Shinden Y, Iguchi T, Eguchi H, Shirabe K, et al:
Identification of a bona fide microRNA biomarker in serum exosomes
that predicts hepatocellular carcinoma recurrence after liver
transplantation. Br J Cancer. 112:532–538. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Pegtel DM, Cosmopoulos K, Thorley-Lawson
DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, de Gruijl TD,
Würdinger T and Middeldorp JM: Functional delivery of viral miRNAs
via exosomes. Proc Natl Acad Sci USA. 107:6328–6333. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Xiao W, Dong W, Zhang C, Saren G, Geng P,
Zhao H, Li Q, Zhu J, Li G, Zhang S, et al: Effects of the
epigenetic drug MS-275 on the release and function of
exosome-related immune molecules in hepatocellular carcinoma cells.
Eur J Med Res. 18:612013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Feng Z, Hensley L, McKnight KL, Hu F,
Madden V, Ping L, Jeong SH, Walker C, Lanford RE and Lemon SM: A
pathogenic picornavirus acquires an envelope by hijacking cellular
membranes. Nature. 496:367–371. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ramakrishnaiah V, Thumann C, Fofana I,
Habersetzer F, Pan Q, de Ruiter PE, Willemsen R, Demmers JA, Stalin
Raj V, Jenster G, et al: Exosome-mediated transmission of hepatitis
C virus between human hepatoma Huh7.5 cells. Proc Natl Acad Sci
USA. 110:13109–13113. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chen TC, Hsieh CH and Sarnow P: Supporting
role for GTPase Rab27a in hepatitis C virus RNA replication through
a novel miR-122-mediated effect. PLoS Pathog. 11:e10051162015.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Tickner JA, Urquhart AJ, Stephenson SA,
Richard DJ and O'Byrne KJ: Functions and therapeutic roles of
exosomes in cancer. Front Oncol. 4:1272014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Huang A, Dong J, Li S, Wang C, Ding H, Li
H, Su X, Ge X, Sun L, Bai C, et al: Exosomal transfer of vasorin
expressed in hepatocellular carcinoma cells promotes migration of
human umbilical vein endothelial cells. Int J Biol Sci. 11:961–969.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
He M, Qin H, Poon TC, Sze SC, Ding X, Co
NN, Ngai SM, Chan TF and Wong N: Hepatocellular carcinoma-derived
exosomes promote motility of immortalized hepatocyte through
transfer of oncogenic proteins and RNAs. Carcinogenesis.
36:1008–1018. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Chiba M, Watanabe N, Watanabe M, Sakamoto
M, Sato A, Fujisaki M, Kubota S, Monzen S, Maruyama A, Nanashima N,
et al: Exosomes derived from SW480 colorectal cancer cells promote
cell migration in HepG2 hepatocellular cancer cells via the
mitogen-activated protein kinase pathway. Int J Oncol. 48:305–312.
2016. View Article : Google Scholar
|
|
58
|
Liu WH, Ren LN, Wang X, Wang T, Zhang N,
Gao Y, Luo H, Navarro-Alvarez N and Tang LJ: Combination of
exosomes and circulating microRNAs may serve as a promising tumor
marker complementary to alpha-fetoprotein for early-stage
hepatocellular carcinoma diagnosis in rats. J Cancer Res Clin
Oncol. 141:1767–1778. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Li Y, Xiang GM, Liu LL, Liu C, Liu F,
Jiang DN and Pu XY: Assessment of endogenous reference gene
suitability for serum exosomal microRNA expression analysis in
liver carcinoma resection studies. Mol Med Rep. 12:4683–4691. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Melo SA, Luecke LB, Kahlert C, Fernandez
AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari
N, et al: Glypican-1 identifies cancer exosomes and detects early
pancreatic cancer. Nature. 523:177–182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Skog J, Würdinger T, van Rijn S, Meijer
DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky
AM and Breakefield XO: Glioblastoma microvesicles transport RNA and
proteins that promote tumour growth and provide diagnostic
biomarkers. Nat Cell Biol. 10:1470–1476. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Tanaka Y, Kamohara H, Kinoshita K,
Kurashige J, Ishimoto T, Iwatsuki M, Watanabe M and Baba H:
Clinical impact of serum exosomal microRNA-21 as a clinical
biomarker in human esophageal squamous cell carcinoma. Cancer.
119:1159–1167. 2013. View Article : Google Scholar
|
|
63
|
Sohn W, Kim J, Kang SH, Yang SR, Cho JY,
Cho HC, Shim SG and Paik YH: Serum exosomal microRNAs as novel
biomarkers for hepatocellular carcinoma. Exp Mol Med. 47:e1842015.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Kogure T, Yan IK, Lin WL and Patel T:
Extracellular vesicle-mediated transfer of a novel long noncoding
RNA TUC339: A mechanism of intercellular signaling in human
hepatocellular cancer. Genes Cancer. 4:261–272. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Mohankumar S and Patel T: Extracellular
vesicle long noncoding RNA as potential biomarkers of liver cancer.
Brief Funct Genomics. 15:249–256. 2016. View Article : Google Scholar :
|
|
66
|
Bandiera S, Pfeffer S, Baumert TF and
Zeisel MB: miR-122 - a key factor and therapeutic target in liver
disease. J Hepatol. 62:448–457. 2015. View Article : Google Scholar
|
|
67
|
Mou DL, Jia ZS and Bai XF: Exosome: Trojan
horse in immunotherapy. Sheng Li Ke Xue Jin Zhan. 36:113–118.
2005.In Chinese. PubMed/NCBI
|
|
68
|
Wang SH, Shen Y, Li J, Xiang ZW, Fan WK
and Chen L: Experimental studies on anti-mouse hepatocellular
carcinoma effects of cisplatin combined with exosomes. Xi Bao Yu
Fen Zi Mian Yi Xue Za Zhi. 25:49–52. 2009.In Chinese. PubMed/NCBI
|
|
69
|
Qu Z, Wu J, Wu J, Luo D, Jiang C and Ding
Y: Exosomes derived from HCC cells induce sorafenib resistance in
hepatocellular carcinoma both in vivo and in vitro. J Exp Clin
Cancer Res. 35:1592016. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Ma B, Jiang H, Jia J, Di L, Song G, Yu J,
Zhu Y, Lu Z, Wang X, Zhou X, et al: Murine bone marrow stromal
cells pulsed with homologous tumor-derived exosomes inhibit
proliferation of liver cancer cells. Clin Transl Oncol. 14:764–773.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Xiao WH, Sanren GW, Zhu JH, Li QW, Kang
HR, Wang RL, Song LP and Ye M: Effect of 5-aza-2′-deoxycytidine on
immune-associated proteins in exosomes from hepatoma. World J
Gastroenterol. 16:2371–2377. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Li QW, Xiao WH, Sarengaowa G, Dong WW,
Zhao HX, Duan XY, Zhu JH, Kang HR, Fu Y, Hao YX, et al: Histone
deacetylase inhibitor MS-275 treatment alters immune molecule
content and categories in hepatocarcinoma exosomes. Zhonghua Gan
Zang Bing Za Zhi. 20:231–235. 2012.In Chinese. PubMed/NCBI
|
|
73
|
Ko SF, Yip HK, Zhen YY, Lee CC, Lee CC,
Huang CC, Ng SH and Lin JW: Adipose-derived mesenchymal stem cell
exosomes suppress hepatocellular carcinoma growth in a rat model:
Apparent diffusion coefficient, natural killer T-cell responses,
and histopathological features. Stem Cells Int. 2015:8535062015.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Zhou W, Fong MY, Min Y, Somlo G, Liu L,
Palomares MR, Yu Y, Chow A, O'Connor ST, Chin AR, et al:
Cancer-secreted miR-105 destroys vascular endothelial barriers to
promote metastasis. Cancer Cell. 25:501–515. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Mincheva-Nilsson L, Baranov V, Nagaeva O
and Dehlin E: Isolation and characterization of exosomes from
cultures of tissue explants and cell lines. Curr Protoc Immunol.
115:14.42.1–14.42.21. 2016. View Article : Google Scholar
|
|
76
|
Lötvall J, Hill AF, Hochberg F, Buzás EI,
Di Vizio D, Gardiner C, Gho YS, Kurochkin IV, Mathivanan S,
Quesenberry P, et al: Minimal experimental requirements for
definition of extracellular vesicles and their functions: A
position statement from the International Society for Extracellular
Vesicles. J Extracell Vesicles. 3:269132014. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Bobrie A and Théry C: Exosomes and
communication between tumours and the immune system: Are all
exosomes equal. Biochem Soc Trans. 41:263–267. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Viaud S, Ploix S, Lapierre V, Théry C,
Commere PH, Tramalloni D, Gorrichon K, Virault-Rocroy P, Tursz T,
Lantz O, et al: Updated technology to produce highly immunogenic
dendritic cell-derived exosomes of clinical grade: a critical role
of interferon-gamma. J Immunother. 34:65–75. 2011. View Article : Google Scholar
|
|
79
|
Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H
and Li G: Phase I clinical trial of autologous ascites-derived
exosomes combined with GM-CSF for colorectal cancer. Mol Ther.
16:782–790. 2008. View Article : Google Scholar : PubMed/NCBI
|
